ERJ staff report (DS)
Evry France - Bio-sourced monomer company Global BioEnergies reported an increased loss for the six months to 31 December 2011. The company said the increased loss was planned and comes as a result of increased spending on facilities to to industrialise the biological isobutene production process.
The company also confirmed its agreement with Synthos SA to develop a commercial process to make butadiene monomer from renewable resources. The agreement includes R&D funding, possible multi-million euro development fees,
royalty payments, shared exploitation rights on the different applications of the molecule and a
EUR 1.4 million equity investment in Global Bioenergies from Synthos, which was finalised in
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Global BioEnergies